RECK Antibodies

Santa Cruz Biotechnology features a diverse variety of RECK monoclonal antibodies for advanced research in cell biology. RECK monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RECK, or Reversion-inducing Cysteine-rich Protein with Kazal Motifs, plays a crucial role in regulating extracellular matrix remodeling and is involved in processes such as cell migration, invasion, and angiogenesis. Understanding RECK function has significant implications for cancer biology and tissue repair, making it an important target for therapeutic interventions and biomarker studies. RECK expression patterns can reveal valuable information about disease progression and treatment effectiveness. Studying RECK interactions with matrix metalloproteinases provides insights into tumor suppression mechanisms. Research focusing on RECK signaling pathways contributes to understanding cellular regulation in both normal and pathological conditions. RECK monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific knowledge and develop innovative therapeutic strategies.